A Novel Intra-aortic Device Designed for Coronary Blood Flow Amplification in Unrevascularizable Patients
- 3 June 2016
- journal article
- research article
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 9 (4) , 315-320
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Long-term survival in patients with refractory anginaEuropean Heart Journal, 2013
- Fatality, morbidity and quality of life in patients with refractory angina pectorisInternational Journal of Cardiology, 2011
- Distribution of left ventricular ejection fraction in angina patients with severe coronary artery disease not amenable to revascularizationCoronary Artery Disease, 2010
- Patients with coronary artery disease not amenable to traditional revascularization: Prevalence and 3‐year mortalityCatheterization and Cardiovascular Interventions, 2010
- Nonrevascularizable coronary artery disease following coronary artery bypass graft surgery: a population-based study in Olmsted County, MinnesotaCoronary Artery Disease, 2009
- Clinical and research issues regarding chronic advanced coronary artery disease Part II: Trial design, outcomes, and regulatory issuesAmerican Heart Journal, 2008
- Clinical and research issues regarding chronic advanced coronary artery diseaseAmerican Heart Journal, 2008
- Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatmentGene Therapy, 2006
- Evidence of a Dominant Backward-Propagating “Suction” Wave Responsible for Diastolic Coronary Filling in Humans, Attenuated in Left Ventricular HypertrophyCirculation, 2006
- Outcomes Following Percutaneous Coronary Intervention in Patients Previously Considered “Without Option”:Journal of Interventional Cardiology, 2004